Publications

Our Publications

22 May 2019 Filip Fratev / Micar21 ACS Med. Chem. Lett.2019106904-910

Discovery of New Classes of Glycine transporter 2 (GlyT2) Inhibitors and GlyT2 Selectivity Studies by Combination of Novel Structural Based Virtual Screening Approach and Free Energy Perturbation (FEP+) Calculations

ACS Med. Chem. Lett.2019106904-910

Publication Date:May 22, 2019

https://pubs.acs.org/doi/10.1021/acsmedchemlett.9b00003#

Copyright © 2019 American Chemical Society

20 March 2019 Filip Fratev / Micar21 Nature Scientific Reports DOI : 10.1038/s41598-019-53133-1

An Improvement of the Free Energy Perturbation (FEP+) Sampling Protocol in Case of Flexible protein Ligand Binding Sites

20 March 2019 Filip Fratev / Micar21 Journal of Biomolecular, Structure, and Dynamics, Nov 2019 Accepted In press.

Discovery of New AKT1 Inhibitors by Combination of In silico Structure Based Virtual Screening Approaches and Biological Evaluations

DOI: 10.1124/pr.118.017178 Tzvetkov, N. T. / Preclinical.Science Pharmacol. Rev. 2019, 71, 596–670. IF = 18.886 (2018)

Targeting foam cell formation in atherosclerosis: Therapeutic potential of natural products.

Wang, D.; Yang, Y.; Lei, Y.; Tzvetkov, N. T.; Liu, X.; Yeung, W. K.; Xu, S.; Atanasov, A. G.

DOI: 10.1016/j.ejmeh.2019.06.041 Tzvetkov, N. T. / Preclinical.Science Eur. J. Med. Chem. 2019, 179, 404–422. IF = 4.833 (2018)

Carboxamides vs. methanimines: Crystal structures, binding interaction, photophysical evaluation of (indazole-5-yl) methanimines as monoamine oxidase B and acetylcholinesterase inhibitors.

Tzvetkov, N. T.; Stammler, H.-G.; Georgieva, M. G.; Russo, D.; Faraone, I.; Balacheva, A. A.; Hristova, S.; Atanasov, A. G.; Milella, L.; Antonov, L.; Gastreich, M.

DOI: 10.1155/2019/8278454 Tzvetkov, N. T. / Preclinical.Science Oxid. Med. Cell. Longev. 2019, Art. ID: 8278454. IF = 4.868 (2018)

Antioxidants: Scientific literature landscape analysis.

Yeung, A. W. K.; Tzvetkov, N. T.; El-Tawil, O. S.; Bungáu, S. G.; Abdel-Daim, M. M.; Atanasov, A. G.

DOI: 10.1016/j.ejmech.2018.11.009 Tzvetkov, N. T. / Preclinical.Science Eur. J. Med. Chem. 2019, 162, 793–809. IF = 4.833 (2018)

(Pyrrolo-pyridin-5-yl)benzamides: BBB permable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons.

Tzvetkov, N. T.; Stammler, H.-G.; Hristova, S.; Atanasov, A. G.; Antonov, L.

DOI: 10.1016/j.ejmech.2018.11.009 Tzvetkov, N. T. / Preclinical.Science Eur. J. Med. Chem. 2019, 162, 793–809. IF = 4.833 (2018)

(Pyrrolo-pyridin-5-yl)benzamides: BBB permable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons.

Tzvetkov, N. T.; Stammler, H.-G.; Hristova, S.; Atanasov, A. G.; Antonov, L.

DOI: 10.1016/j.ejmech.2018.11.009 Tzvetkov, N. T. / Preclinical.Science Eur. J. Med. Chem. 2019, 162, 793–809. IF = 4.833 (2018)

(Pyrrolo-pyridin-5-yl)benzamides: BBB permable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons.

Tzvetkov, N. T.; Stammler, H.-G.; Hristova, S.; Atanasov, A. G.; Antonov, L.

DOI: 10.1016/j.ejmech.2018.11.009 Tzvetkov, N. T. / Preclinical.Science Eur. J. Med. Chem. 2019, 162, 793–809. IF = 4.833 (2018)

(Pyrrolo-pyridin-5-yl)benzamides: BBB permable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons.

Tzvetkov, N. T.; Stammler, H.-G.; Hristova, S.; Atanasov, A. G.; Antonov, L.

DOI: 10.1016/j.ejmech.2018.11.009 Tzvetkov, N. T. / Preclinical.Science Eur. J. Med. Chem. 2019, 162, 793–809. IF = 4.833 (2018)

(Pyrrolo-pyridin-5-yl)benzamides: BBB permable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons.

Tzvetkov, N. T.; Stammler, H.-G.; Hristova, S.; Atanasov, A. G.; Antonov, L.

DOI: 10.1016/j.ejmech.2018.11.009 Tzvetkov, N. T. / Preclinical.Science Eur. J. Med. Chem. 2019, 162, 793–809. IF = 4.833 (2018)

(Pyrrolo-pyridin-5-yl)benzamides: BBB permable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons.

Tzvetkov, N. T.; Stammler, H.-G.; Hristova, S.; Atanasov, A. G.; Antonov, L.

DOI: 10.1016/j.ejmech.2018.11.009 Tzvetkov, N. T. / Preclinical.Science Eur. J. Med. Chem. 2019, 162, 793–809. IF = 4.833 (2018)

(Pyrrolo-pyridin-5-yl)benzamides: BBB permable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons.

Tzvetkov, N. T.; Stammler, H.-G.; Hristova, S.; Atanasov, A. G.; Antonov, L.

DOI: 10.1016/j.ejmech.2018.11.009 Tzvetkov, N. T. / Preclinical.Science Eur. J. Med. Chem. 2019, 162, 793–809. IF = 4.833 (2018)

(Pyrrolo-pyridin-5-yl)benzamides: BBB permable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons.

Tzvetkov, N. T.; Stammler, H.-G.; Hristova, S.; Atanasov, A. G.; Antonov, L.

DOI: 10.1016/j.ejmech.2018.11.009 Tzvetkov, N. T. / Preclinical.Science Eur. J. Med. Chem. 2019, 162, 793–809. IF = 4.833 (2018)

(Pyrrolo-pyridin-5-yl)benzamides: BBB permable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons.

Tzvetkov, N. T.; Stammler, H.-G.; Hristova, S.; Atanasov, A. G.; Antonov, L.